Dai‐Hong Liu
Chongqing University(CN)Capital Medical University(CN)Nankai University(CN)Chinese PLA General Hospital(CN)307th Hospital of Chinese People’s Liberation Army(CN)People's Liberation Army No. 150 Hospital(CN)Chongqing Cancer Hospital(CN)PLA Academy of Military Science(CN)
Publications by Year
Research Areas
Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Cytomegalovirus and herpesvirus research, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Who is the best donor for a related HLA haplotype-mismatched transplant?(2014)352 cited
- → MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial(2013)322 cited
- → The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update(2021)299 cited
- → Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation(2009)292 cited
- → The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology(2018)291 cited
- → Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation